USANA Health Sciences (USNA) Tops Q2 EPS by 16c; Reiterates Guidance
Tweet
Share
E-mailGet Alerts USNA Hot Sheet
Price: $14.49 +2.48%
EPS Growth %: +386.7%
Financial Fact:
Interest expense: -46K
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: +386.7%
Financial Fact:
Interest expense: -46K
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
USANA Health Sciences (NYSE: USNA) reported Q2 EPS of $1.87, $0.16 better than the analyst estimate of $1.71. Revenue for the quarter came in at $336.8 million versus the consensus estimate of $332.61 million.
GUIDANCE:
Reiterates 2021 net sales and diluted EPS outlook.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Microchip Technology completes acquisition of Hailo
- UBS Downgrades Buzzi Unicem SpA (BZU:IM) (BZZUY) to Sell
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
